abstract |
The present invention relates generally to novel antiviral agents. In particular, the present invention relates to compounds capable of inhibiting protein(s) encoded by hepatitis B virus (HBV) or interfering with the function of the HBV replication cycle, compositions comprising such compounds, methods of inhibiting HBV virus replication, It relates to methods of treating or preventing HBV infection, and methods and intermediates for preparing the compounds. |